Loading...
Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
A majority of patients with BRAF-mutated metastatic melanoma respond to therapy with BRAF inhibitors (BRAFi), but relapses are common owing to acquired resistance. To unravel BRAFi resistance mechanisms we have performed gene expression and mass spectrometry based proteome profiling of the sensitive...
Na minha lista:
| Udgivet i: | Cell Death Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5596587/ https://ncbi.nlm.nih.gov/pubmed/29048432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.406 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|